RESISTANCE OF TRANSGENIC MICE EXPRESSING HUMAN GROUP II PHOSPHOLIPASE A2 TO E. COLI INFECTION

Shock ◽  
1997 ◽  
Vol 7 (Supplement) ◽  
pp. 24 ◽  
Author(s):  
V JO Laine ◽  
T J Nevalainen ◽  
D S Grass
2000 ◽  
Vol 68 (1) ◽  
pp. 87-92 ◽  
Author(s):  
V. Jukka O. Laine ◽  
David S. Grass ◽  
Timo J. Nevalainen

ABSTRACT Group II phospholipase A2 (PLA2) is a newly recognized antibacterial acute-phase protein. Recently we observed that transgenic mice expressing group II PLA2 (PLA2+ mice) were able to resist experimental Staphylococcus aureusinfection by killing the bacteria, as indicated by improved survival and by the small numbers of live bacteria in their tissues (V. J. O. Laine, D. S. Grass, and T. J. Nevalainen, J. Immunol. 162:7402–7408, 1999). To establish the role of group II PLA2 in Escherichia coli infection, the host responses of PLA2+ mice and their PLA2-deficient C57BL/6J littermates (PLA2− mice) were studied after intraperitoneal administration of E. coli. The levels of group II PLA2 in sera of PLA2+ mice increased after the administration ofE. coli, and the concentration of group II PLA2 correlated significantly with the catalytic activity of PLA2 in serum. PLA2+ mice showed lower rates of mortality and less bacterial growth in peritoneal lavage fluid, blood, and spleen and liver tissues than PLA2− mice. Unlike the observations with staphylococcal infection, serum and peritoneal lavage fluid did not inhibit the growth of E. coli in vitro. The results indicate that expression of the group II PLA2 transgene improves the host defense of mice against E. coliinfection.


1994 ◽  
Vol 22 (3) ◽  
pp. 317S-317S ◽  
Author(s):  
ROOHAIDA OTHMAN ◽  
ANDREW WORRALL ◽  
DAVID C. WILTON

2004 ◽  
Vol 36 (9) ◽  
pp. 583-588 ◽  
Author(s):  
Hong-Qiang Cheng ◽  
Gen-Jun Xu

Abstract Human group IB phospholipase A2 (IB-PLA2) and its zymogen (proIB-PLA2) were purified from E. coli. Refolding was carried out by diluting the denatured forms of both IB-PLA2 and proIB-PLA2 with renaturation buffer in which the disulfide bonds were completely reduced. The refolding yield of proIB-PLA2 was increased by about 50% over that of the mature enzyme. The refolding of IB-PLA2 usually produced aggregates under normal conditions, as determined by light scattering. In addition, the unfolding experiments showed that the mature enzyme was more stable than the proenzyme toward denaturants in the presence of DTT. Results suggested that the N-terminal sequence rather than its conformation of human proIB-PLA2 played an important role in the refolding process.


1995 ◽  
Vol 11 (2) ◽  
pp. 187-200 ◽  
Author(s):  
Peter Vadas ◽  
Eva Stefanski ◽  
Brigitte Grouix ◽  
B.Diana Schouten ◽  
Waldemar Pruzanski

1997 ◽  
Vol 327 (1) ◽  
pp. 259-265 ◽  
Author(s):  
János POLGÁR ◽  
Ruth M. KRAMER ◽  
Suzane L. UM ◽  
Joseph A. JAKUBOWSKI ◽  
Kenneth J. CLEMETSON

Recombinant human group II phospholipase A2 (sPLA2) added to human platelets in the low μg/ml range induced platelet activation, as demonstrated by measurement of platelet aggregation, thromboxane A2 generation and influx of intracellular free Ca2+ concentration and by detection of time-dependent tyrosine phosphorylation of platelet proteins. The presence of Ca2+ at low millimolar concentrations is a prerequisite for the activation of platelets by sPLA2. Mg2+ cannot replace Ca2+. Mg2+, given in addition to the necessary Ca2+, inhibits sPLA2-induced platelet activation. Pre-exposure to sPLA2 completely blocked the aggregating effect of a second dose of sPLA2. Albumin or indomethacin inhibited sPLA2-induced aggregation, similarly to the inhibition of arachidonic acid-induced aggregation. Platelets pre-treated with heparitinase or phosphatidylinositol-specific phospholipase C lost their ability to aggregate in response to sPLA2, although they still responded to other agonists. This suggests that a glycophosphatidylinositol-anchored platelet-membrane heparan sulphate proteoglycan is the binding site for sPLA2 on platelets. Previous reports have stated that sPLA2 is unable to activate platelets. The inhibitory effect of albumin and Mg2+, frequently used in aggregation studies, and the fact that isolated platelets lose their responsiveness to sPLA2 relatively quickly, may explain why the platelet-activating effects of sPLA2 have not been reported earlier.


1996 ◽  
Vol 97 (10) ◽  
pp. 2233-2241 ◽  
Author(s):  
D S Grass ◽  
R H Felkner ◽  
M Y Chiang ◽  
R E Wallace ◽  
T J Nevalainen ◽  
...  

1997 ◽  
Vol 45 (8) ◽  
pp. 1109-1119 ◽  
Author(s):  
Timo J. Nevalainen ◽  
V. Jukka O. Laine ◽  
David S. Grass

Group II phospholipase A2 (PLA2) has been proposed to play an important role in inflammation and defense against bacterial infection. We investigated tissues of transgenic mice expressing the human group II PLA2 gene by immunohistochemistry using rabbit anti-human group II PLA2 antibodies, and by in situ hybridization by probing with human group II PLA2 mRNA anti-sense (test) and sense (control) riboprobes. By immunohis-tochemistry, human group II PLA2 was found in various mouse tissues and cell types including hepatocytes, proximal tubule cells of the kidney, epithelial cells of the renal pelvis, urinary bladder and ureter, granulosa cells of Graafian follicles, aortic intima and media, cartilage, epiphyseal bone, bronchial epithelial cells, and connective tissue cells in the dermis. By in situ hybridization, group II PLA2 mRNA was localized in hepatocytes, epidermal cells, dermal cells, connective tissue fibroblasts, epithelial and smooth muscle cells of the urinary bladder, and cells of Bowman's capsule. These results show that human group II PLA2 is expressed in large amounts in hepatocytes and many extrahepatic tissues of the transgenic mice. These animals provide a useful new tool for studies on the metabolism, in vivo effects, and physiological and pathological roles of phospholipase A2. (J Histochem Cytochem 45:1109–1119, 1997)


1994 ◽  
Vol 47 (6) ◽  
pp. 631-638 ◽  
Author(s):  
KAZUSHIGE TANAKA ◽  
SHIGERU MATSUTANI ◽  
AKIKO KANDA ◽  
TOSHIYUKI KATO ◽  
TADASHI YOSHIDA

1993 ◽  
Vol 4 (5) ◽  
pp. 490-498 ◽  
Author(s):  
N.M. Tremblay ◽  
B.P. Kennedy ◽  
I.P. Street ◽  
W.J. Kaupp ◽  
F. Laliberte ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document